Evidence map›Paper›PMID 36905487›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2023

Bacterial profile, antimicrobial resistance, and molecular detection of ESBL and quinolone resistance gene of uropathogens causing urinary tract infection in the southeastern part of Bangladesh.

Khandokar Fahmida Sultana, Asma Akter, Sumita Rani Saha, Firoz Ahmed, Sameeha Alam, Tamanna Jafar, Otun Saha

Open access · greenAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Mutation analysis of dihydrofolate reductase (Iranian journal of microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Khandokar Fahmida SultanaDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Asma AkterDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Sumita Rani SahaDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Firoz AhmedDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Sameeha AlamDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Tamanna JafarDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh.
Otun SahaDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, Bangladesh. otun.saha@nstu.edu.bd.ORCID http://orcid.org/0000-0001-9159-0437
Noakhali Science and Technology University · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Humans frequently contract urinary tract infections (UTIs), which can be brought on by uropathogens (UPs) that are multi-drug resistant. Treatment for UTIs brought on by pathogenic UPs that produce extended-spectrum lactamases (ESBLs) is more costly and potentially fatal. As a result, the objective of this study was to use culture, biochemical, and 16S rRNA sequencing to identify and characterize UPs isolated from outpatients in Noakhali, Bangladesh, who had symptoms of UTIs. ESBL gene identification and quinolone resistance gene typing were then performed on the isolates using polymerase chain reaction (PCR). Throughout the trial's 8-month duration, 152 (76%) of 200 urine samples were positive for the presence of UPs. The overall number of UPs recovered was 210, with 39 individuals having multiple UPs present in their samples. Among all of the isolates, Escherichia coli (45.24%, 95/210; 95% confidence interval (CI): 35.15-57.60%), Enterobacter spp. (24.76%, 52/210; CI: 19.15-35.77%), Klebsiella spp. (20.95%; 44/210; CI: 15.15-30.20%), and Providencia spp. (9.05%; 19/210; CI: 4.95-19.25%) were the four most prevalent bacteria found in the isolates. The UPs displayed a very high level of resistance to piperacillin 96.92% (126/130), ampicillin 90% (117/130), nalidixic acid 77.69% (101/130), cefazolin 70% (91/130), amoxicillin 50% (55/130), cefazolin 42.31% (55/130), nitrofurantoin 43.08% (56/130), and ciprofloxacin 33.08% (43/130), whereas resistance to netilmicin (3.85%), amikacin (4.62%), and imipenem (9.23%) was low. Individually, every species of E. coli and Providencia spp. showed greater ampicillin, amikacin, cefazolin, cefazolin, and nalidixic acid resistance than the others. The bivariate results indicate several antibiotic pairings, and isolates had meaningful associations. All MDR isolates were subjected to PCR, which revealed that bla

Indexed as

Escherichia coli InfectionsQuinolonesUrinary Tract InfectionsAmikacinAmpicillinAnti-Bacterial AgentsBangladeshbeta-LactamasesCefazolinDrug Resistance, BacterialDrug Resistance, Multiple, BacterialEscherichia coliHumansMicrobial Sensitivity TestsNalidixic AcidRNA, Ribosomal, 16SAmikacinAmpicillinAnti-Bacterial Agentsbeta-LactamasesCefazolinNalidixic AcidQuinolonesRNA, Ribosomal, 16SCo-infectionESBLMDRPCRUropathogens

Identifiers

PMID36905487
PMCPMC10235015
OpenAlexW4323920731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.